Shi, M., Ma, T., Xi, W., Jiang, J., Wu, J., Zhou, C., . . . Zhang, J. (2020). A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer. Trials.
Citação norma ChicagoShi, Min, Tao Ma, Wenqi Xi, Jinling Jiang, Junwei Wu, Chenfei Zhou, Chen Yang, Zhenggang Zhu, and Jun Zhang. "A Study of Capecitabine Metronomic Chemotherapy Is Non-inferior to Conventional Chemotherapy As Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer." Trials 2020.
ציטוט MLAShi, Min, et al. "A Study of Capecitabine Metronomic Chemotherapy Is Non-inferior to Conventional Chemotherapy As Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer." Trials 2020.